A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
You might remember them as the National Federation of Parents for Drug Free Youth, from back in the 1980s, but today, the renamed National Family Partnership continues its work to support families and ...
Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.
The Canadian Press on MSN
Health Canada authorizes long-awaited drug to slow early-stage Alzheimer's disease
TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease. Lecanemab is the first ...
A well-structured plan provides a roadmap for care, helps prevent crises, and ensures that your loved one’s dignity and quality of life remain central to every decision.
New research suggests that psychedelic drugs may work by strengthening specific brain connections linked to memory and cognition.
Dr. Joel Salinas, founder and chief medical officer of Isaac Health, examines the growing dementia crisis as a looming ...
A major study led by the University of Cambridge has revealed that problems with the brain’s waste clearance system may ...
Impaired movement of cerebrospinal fluid — the clear liquid that cushions and cleans the brain — predicted people’s risk of ...
In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT ...
A new study brings good news for older adults with high blood pressure. It shows that taking blood pressure medicine might ...
Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results